BIOMAT Database Logo BIOMAT Database Logo

Contribution of acute rejection to renal allograft loss from chronic rejection. 1993

N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
Department of Surgery, State University of New York Health Science Center, Brooklyn 11203.

UI MeSH Term Description Entries
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000961 Antilymphocyte Serum Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION. ATGAM,Antilymphoblast Globulins,Antilymphocyte Antibodies,Antilymphocyte Globulin,Lymphocytotoxic Antibodies,Anti-Thymocyte Globulin,Antilymphocyte Immunoglobulin,Antithymocyte Globulin,Antithymoglobulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin,Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine),Pressimmune,Anti Thymocyte Globulin,Anti-Thymocyte Globulins,Antibodies, Antilymphocyte,Antibodies, Lymphocytotoxic,Antibody, Antilymphocyte,Antibody, Lymphocytotoxic,Antilymphoblast Globulin,Antilymphocyte Antibody,Antilymphocyte Globulins,Antilymphocyte Immunoglobulins,Antilymphocyte Serums,Antithymocyte Globulins,Antithymoglobulins,Globulin, Anti-Thymocyte,Globulin, Antilymphoblast,Globulin, Antilymphocyte,Globulin, Antithymocyte,Globulins, Anti-Thymocyte,Globulins, Antilymphoblast,Globulins, Antilymphocyte,Globulins, Antithymocyte,Immunoglobulin, Antilymphocyte,Immunoglobulins, Antilymphocyte,Lymphocyte Immune Globulin, Anti Thymocyte Globulin,Lymphocytotoxic Antibody,Serum, Antilymphocyte,Serums, Antilymphocyte

Related Publications

N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
Contribution of late acute rejection to long-term renal allograft survival in patients with chronic allograft nephropathy.
November 2003, Transplantation proceedings,
N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
Late renal allograft loss: noncompliance masquerading as chronic rejection.
June 1999, Transplantation proceedings,
N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
Early versus late acute renal allograft rejection: impact on chronic rejection.
May 1993, Transplantation,
N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
Clinical correlates to chronic renal allograft rejection.
December 1997, Kidney international. Supplement,
N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.
June 2000, Transplantation,
N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
Acute humoral renal allograft rejection.
March 2002, Current opinion in urology,
N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
January 2001, Transplantation proceedings,
N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
Pathophysiology of chronic renal allograft rejection.
November 1999, Transplantation proceedings,
N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
The role of chemokines in acute renal allograft rejection and chronic allograft injury.
January 2009, Frontiers in bioscience (Landmark edition),
N Sumrani, and T V Cacciarelli, and B Georgi, and P Daskalakis, and A M Miles, and K Goldberg, and J H Hong, and B G Sommer
Chronic renal allograft loss.
July 1994, Current opinion in nephrology and hypertension,
Copied contents to your clipboard!